Per-Se appoints new CEO following Ritchie departure

Article

Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the

Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the positions of executive vice president and COO for the firm. Per-Se provides business management services to physicians and claims to support 35,000 physicians and 2000 healthcare organizations.


© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.